Review: Polymerase chain reaction detection of micrometastases and circulating tumor cells: Application to melanoma, prostate, and thyroid carcinomas

Diagnostic Molecular Pathology

Volumn 8, Issue 4, 1999, Pages 165-175

  Ghossein, Ronald A ^a   Carusone, Leo ^a   Bhattacharya, Satyajit ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Malignant melanoma; Minimal residual disease; Molecular diagnostics; Polymerase chain reaction; Prostatic carcinoma; Reverse transcriptase; Thyroid carcinoma

Indexed keywords

BONE MARROW METASTASIS; CANCER LOCALIZATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; MELANOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; REVIEW; THYROID CARCINOMA;

HUMANS; MALE; MELANOMA; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THYROID NEOPLASMS;

EID: 0343446134     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199912000-00001     Document Type: Review

References (88)

1. Ashworth TR. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 1869; 14:146.
2. Axelrod HR, Gilman SC, D'aleo CJ, et al. Preclinical results and immunohistochemical studies with 90Y-CYT-356: a new prostatic cancer therapeutic agent [abstract]. J Urol 1992;147:361A.
3. Battayani Z, Grob JJ, Xerri L, et al. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 1995;131:443-7.
4. Biegliek SC, Ghossein RA, Rosai J, Bhattacharya S, Coit DG. The detection of tyrosinase mRNA by reverse transcriptase polymerase chain reaction (RT-PCR) in melanoma sentinel nodes. Ann Surg Oncol 1999;6:232-40.
5. Brisco MJ, Condon J, Hughes E, et al. Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet 1994;343: 196-200.
6. Brossart P, Keiholz U, Willhauck M, Scheibenbogen C, Mohler T, Hunstein W. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 1993;101:887-9.
7. Brossart P, Schmier JW, Kruger S, Willhauck M, Scheibenbogen C, Mohler T, Keilholz U. A polymerase chain reaction based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 1995;55:4065-8.
8. Buzaid AC, Balch CM. Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value. J Natl Cancer Inst 1996;88:569-70.
9. Campana D, Pui CH. Detection of minimal residual disease in acute leukemias: methodological advances and clinical significance. Blood 1995;85:1416-34.
10. Cave H, Guidal P, Rohrlich P, et al. Prospective monitoring and quantitation of residual blasts in childhood acute leukemias by polymerase chain reaction of delta and gamma T-cell receptor genes. Blood 1994;83:1892-902.
11. Christopherson W. Cancer cells in the peripheral blood: a second look. Acta Cytol 1965;9:169-74.
12. Coit D, Ghossein RA, Vlamis V, et al. Prognostic significance of detection of tyrosinase mRNA in the peripheral blood and/or bone marrow of melanoma patients rendered surgically free of disease. Presented at the 1998 annual meeting of the American Society of Clinical Oncology, Los Angeles, CA [abstract 1981].
13. Corey E, Arfman EW, Oswin MM, et al. Detection of circulating prostatic cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (Hk2) and prostatic-specific antigen (PSA) messages. Urology 1997;50:184-8.
14. Courtemanche DJ, Worth AJ, Coupland RW, MacFarlane JK. Detection of micrometastases from primary breast cancer. Can J Surg 1991;34:15-9.
15. Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM. Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993;82:1929-36.
16. Curry BJ, Myers K, Hersey P. Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma. J Clin Oncol 1998;16:1760-9.
17. Deguchi T, Doi T, Ehara H, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993;53:5350-4.
18. de la Taille A, Olsson CA, Katz AE. Molecular staging of prostate cancer: dream or reality? Oncology 1999;13:187-94.
19. Diel IJ, Kaufman M, Goerner R, Costa SD, Kaul S, Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 1992;10:1534-9.
20. Ditkoff BA, Marvin MR, Yemul S, et al. Detection of circulating thyroid cells in peripheral blood. Surgery 1996;120:959-65.
21. Eeles RA, Janssen JGW. Polymerase chain reaction: the technique and its applications. Austin, TX: R.G. Landes Cie, 1993.
22. Edelstein RA, Zietman AL, de las Morenas A, et al. Implication of prostatic micrometastases to the pelvic lymph nodes: an archival tissue study. Urology 1996;47:370-5.
23. Ellis WJ, Vessella RL, Corey E, Arfman EW, Oswin MM, Melchior S, Lange PH. The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and follow up of patients with prostate cancer. J Urol 1998;159(4):1134-8.
24. Engell HC. Cancer cells in the circulating blood. Acta Chir Scand 1955;(Suppl):201.
25. Ennis RD, Katz AE, de Vries GM, et al. Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Cancer 1997;79:2402-8.
26. Farthman B, Eberle J, Krasagakis K, Gstottner M, Wang N, Bisson S, Orfanos CE. RT PCR for tyrosinase mRNA positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 1998;110:263-7.
27. Foss AJ, Guille MJ, Occleston NL, Hykin PG, Hungerford JL, Lightman S. The detection of melanoma cells in peripheral blood by reverse transcriptase polymerase chain reaction. Br J Cancer 1995;72:155-9.
28. Fukuhara T, Hooper WC, Baylin SB, et al. Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene-a new, sensitive approach to monitor tumor cells in acute myelogenous leukemia. Leuk Res 1992;16:1031-40.
29. Gao C-L, Maheshwari S, Dean RC, et al. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer. Urology 1999;53:714-21.
30. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725-9.
31. Ghossein RA, Coit D, Brennan M, et al. Prognostic significance of peripheral blood and bone marrow tyrosinase mRNA in malignant melanoma. Clin Cancer Res 1998;4:419-28.
32. Ghossein RA, Osman I, Bhattacharya S, Ferrara J, Fazzari M, Scher HI. Detection of circulating tumor cells in prostatic carcinoma using immunobead reverse transcriptase polymerase chain reaction for prostatic specific membrane antigen mRNA [abstract]. Mod Pathol 1999;12:96A.
33. Ghossein R, Rosai J, Scher HI, et al. Prognostic significance of detection of prostate specific antigen transcripts in the peripheral blood of patients with metastatic androgen independent prostatic carcinoma. Urology 1997;50:100-5.
34. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF, Rosai J. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 1995;13:1195-200.
35. Gomella LG, Raj GV, Moreno JG. Reverse-transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J Urol 1997;158:326-37.
36. Grasso YZ, Gupta MK, Levin HS, et al. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. Cancer Res 1998 58:1456-9.
37. Heid CA, Stevens J, Livak KJ, Mickey Williams P. Real time quantitative PCR. Genome Res 1996;6:986-94.
38. Hoon DSB, Wang Y, Dale PS, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995;13:2109-16.
39. Israeli R, Miller WH, Su SL, et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostatic-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 1994; 54:6306-10.
40. Johnson PWM, Burchill SA, Selby PJ. The molecular detection of circulating tumor cells. Br J Cancer 1995;72:268-76.
41. Kaplan JC, Kahn A, Chelly J. Illegitimate transcription: its use in the study of inherited disease. Hum Mutat 1992;1:357-60.
42. Katz AE, Olsson CA, Raffo AJ, et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1994;43:765-75.
43. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988;85: 5698-702.
44. Keiljolz U. New prognostic factors in melanoma: mRNA tumour markers. Eur J Cancer 1998;34:S37-S41.
45. Kirk SJ, Cooper GG, Hoper M, Watt PC, Roy AD, Odling-Smee W. The prognostic significance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 1990;16:481-5.
46. Komeda T, Fukuda Y, Sando T, et al. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995;75:2214-9.
47. Kunter U, Buer J, Probst M, et al. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 1996;88:590-4.
48. Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM, Stass SA. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 1987;237:175-8.
49. Lindemann F, Schlimock G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal patients. Lancet 1992;340:685-9.
50. Martin VM, Siewert C, Scharl A, et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 1998;26:252-64.
51. Mattano LA, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992;52:4701-5.
52. Miettinen M. Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am J Pathol 1991; 138:505-13.
53. Mellado B, Colomer D, Castel T, et al. Detection of circulating neoplastic cells by reverse transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 1996;14:2091-7.
54. Meijerink JP, Smetsers TF, Raemaekers JM, Bogman MJ, De Witte T, Mensink EJ. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reaction. Br J Haematol 1993;84:250-6.
55. Meyers F, de Vere WRW, Larkin E, et al. Bone marrow molecular staging of prostatic carcinoma: does it help? [abstract] Proc Am Soc Clin Oncol 1995;14:230.
56. Miyajama Y, Kato K, Numata S, Kudo K, Horibe K. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 1995;75:2757-61.
57. Moss TJ, Sanders DG. Detection of neuroblastoma cells in blood. J Clin Oncol 1990;8:736-40.
58. Muhlbauer M, Langenbach N, Stolz W, Hein R, Landthaler M, Buettner R, Bosserhoff AK. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription PCR. Clin Cancer Res 1999;5:1099-105.
59. Olsson CA, de Vries GM, Buttyan R, Katz AE. Reverse transcriptase-polymerase chain reaction for prostate cancer. Urol Clin North Am 1997;24:367-78.
60. Olsson CA, de Vries GM, Raffo AJ, et al. Preoperative reverse transcriptase polymerase chain reaction for prostatic specific antigen predicts treatment failure following radical prostatectomy. J Urol 1996;155:1557-62.
61. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, Riethmuller G. Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small cell lung cancer without overt metastases. Lancet 1996;347:649-53.
62. Pelkey TJ, Frierson HF, Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996;42:1369-81.
63. Pittman K, Burchill S, Smith B, Southgate J, Joffe J, Gore M, Selby P. Reverse transcriptase -polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 1996;7:297-301.
64. Price DK, Woodard WL, Teigland CM. Simultaneous detection of prostate specific antigen-expressing and prostate-specific membrane antigen expressing cells by a multiplex reverse transcriptase polymerase chain reaction assay. Urol Oncol 1995;1:226-33.
65. Qiu SD, Young CY, Bilhartz DL, Prescott JL, Farrow GM, He WW, Tindall DJ. In situ hybridization of prostatic-specific antigen mRNA in human prostate. J Urol 1990;144:1550-6.
66. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, Uhr JW. Detection and characterization of carcinoma cells in blood. Proc Natl Acad Sci USA 1998;95:4589-94.
67. Redding WH, Coombes RC, Monaghan P, et al. Detection of micrometastases in patients with primary breast cancer. Lancet 1983; 2:1271-3.
68. Ringel MD, Ladenson PW, Levine MA. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 1998;83:4435-42.
69. Salvadori B, Squicciarni P, Rovini D, et al. Use of monoclonal antibody Mbr1 to detect micrometastases in bone marrow specimens of breast cancer patients. Eur J Cancer 1990;26:865-7.
70. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, Coombes RC. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994;54:2986-90.
71. Seiden MV, Kantoff PW, Krithivas K, et al. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 1995;12:2634-9.
72. Shen R, Su Z, Olsson CA, Fisher PB. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 1995;92: 6778-82.
73. Shivers SC, Wang X, Li W, et al. Molecular staging of malignant melanoma. JAMA 1998;280:1410-5.
74. Singletary SE, Larry L, Tucker SL, Spitzer G. Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol 1991;47:32-6.
75. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338:1227-9.
76. Sokoloff MH, Tso CL, Kaboo R, et al. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clnicopathological molecular analysis of 121 patients. J Urol 1996;156:1560-6.
77. Stahel RA, Mabry M, Skarkin AT, Speak J, Bernal SD. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 1985;3:455-6.
78. Sugarbaker PH. Metastatic inefficiency: the scientific basis for resection of liver metastases from colorectal cancer. J Surg Oncol 1993;(Suppl)3:158-60.
79. Sun Y, Lin J, Katz AE, Fisher PB. Human prostatic carcinoma PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples. Cancer Res 1997;57:18-23.
80. Tallini G, Ghossein RA, Emanuel J, et al. Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 1998;16:1158-66.
81. Thomas P, Battifora H. Keratins versus epithelial membrane antigen in tumor diagnosis-an immunohistochemical comparison of five monoclonal antibodies. Hum Pathol 1987;18:728-34.
82. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768-74.
83. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990;54:159-211.
84. Wingo ST, Ringel MD, Anderson JS, et al. Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem 1999;45;785-9.
85. Wood DP, Banerjee M. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease free survival. J Clin Oncol 1997;15:3451-7.
86. Wright GL, Jr., Haley C, Beckett ML, Schellhammer PF. Expression of the prostate biomarker 7E11-C5 in primary and metastatic prostatic carcinoma [abstract]. Proc Am Assoc Cancer Res 1994; 35:233A.
87. Wright GL, Jr., Haley C, Beckett ML, Schellhammer PF. Expression of prostate-specific membrane antigen in normal, benign and malignant prostatic tissue. Urol Oncol 1995;1:18-28.
88. Young CYF, Montgomery BT, Andrews PE, Qui SD, Bilhartz DL, Tindall DJ. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 1991;51:3748-52.